Jean-François Vanbellinghen

989 total citations
18 papers, 542 citations indexed

About

Jean-François Vanbellinghen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Jean-François Vanbellinghen has authored 18 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Jean-François Vanbellinghen's work include Pituitary Gland Disorders and Treatments (7 papers), Neuroendocrine Tumor Research Advances (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Jean-François Vanbellinghen is often cited by papers focused on Pituitary Gland Disorders and Treatments (7 papers), Neuroendocrine Tumor Research Advances (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Jean-François Vanbellinghen collaborates with scholars based in Belgium, United States and United Kingdom. Jean-François Vanbellinghen's co-authors include Laurence Seidel, Frédéric Baron, Yves Béguin, Georges Fillet, Kaoutar Hafraoui, Étienne Baudoux, France Bruck, Chantal Lechanteur, Évelyne Willems and Marie Lejeune and has published in prestigious journals such as Journal of Biological Chemistry, Brain and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jean-François Vanbellinghen

17 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean-François Vanbellinghen Belgium 10 154 149 138 110 100 18 542
Ken Morii Japan 17 220 1.4× 233 1.6× 70 0.5× 32 0.3× 117 1.2× 54 742
Heather A. O’Leary United States 14 182 1.2× 314 2.1× 360 2.6× 104 0.9× 70 0.7× 26 869
Robert Bayer United States 17 130 0.8× 131 0.9× 215 1.6× 14 0.1× 104 1.0× 23 754
Balázs Csernus United States 15 173 1.1× 141 0.9× 53 0.4× 55 0.5× 10 0.1× 22 535
Jeffrey S. Huo United States 18 49 0.3× 392 2.6× 169 1.2× 163 1.5× 36 0.4× 32 761
Dag Josefsen Norway 14 82 0.5× 222 1.5× 117 0.8× 12 0.1× 98 1.0× 38 608
Maree V. Hammett Australia 16 40 0.3× 222 1.5× 153 1.1× 131 1.2× 54 0.5× 21 1.1k
Marta Albajar Spain 11 53 0.3× 481 3.2× 91 0.7× 43 0.4× 106 1.1× 22 698
Francesca Crosti Italy 14 87 0.6× 278 1.9× 266 1.9× 16 0.1× 96 1.0× 40 884
Tomiaki Asai Japan 11 37 0.2× 135 0.9× 41 0.3× 38 0.3× 42 0.4× 20 483

Countries citing papers authored by Jean-François Vanbellinghen

Since Specialization
Citations

This map shows the geographic impact of Jean-François Vanbellinghen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-François Vanbellinghen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-François Vanbellinghen more than expected).

Fields of papers citing papers by Jean-François Vanbellinghen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-François Vanbellinghen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-François Vanbellinghen. The network helps show where Jean-François Vanbellinghen may publish in the future.

Co-authorship network of co-authors of Jean-François Vanbellinghen

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-François Vanbellinghen. A scholar is included among the top collaborators of Jean-François Vanbellinghen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-François Vanbellinghen. Jean-François Vanbellinghen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Eisermann, Monika, Nadia Bahi‐Buisson, Jean-François Vanbellinghen, et al.. (2013). Not All Myoclonic Jerking and Tonic Posturing in the Neonate Is Epilepsy. The Journal of Pediatrics. 164(3). 664–664.e1. 1 indexed citations
2.
Thomas, Rhys H., Seo‐Kyung Chung, Thomas D. Cushion, et al.. (2013). Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay. Brain. 136(10). 3085–3095. 54 indexed citations
3.
Canaff, Lucie, Jean-François Vanbellinghen, Hiroshi Kaji, David Goltzman, & Geoffrey N. Hendy. (2012). Impaired Transforming Growth Factor-β (TGF-β) Transcriptional Activity and Cell Proliferation Control of a Menin In-frame Deletion Mutant Associated with Multiple Endocrine Neoplasia Type 1 (MEN1). Journal of Biological Chemistry. 287(11). 8584–8597. 22 indexed citations
4.
Canaff, Lucie, et al.. (2011). Menin Missense Mutants Encoded by the MEN1 Gene that Are Targeted to the Proteasome: Restoration of Expression and Activity by CHIP siRNA. The Journal of Clinical Endocrinology & Metabolism. 97(2). E282–E291. 39 indexed citations
5.
Tsai, Kate L., Rooksana E. Noorai, Jean-François Vanbellinghen, et al.. (2011). A canine BCAN microdeletion associated with episodic falling syndrome. Neurobiology of Disease. 45(1). 130–136. 43 indexed citations
6.
Gill, Jennifer, Jean-François Vanbellinghen, Seo‐Kyung Chung, et al.. (2011). Startle disease in Irish wolfhounds associated with a microdeletion in the glycine transporter GlyT2 gene. Neurobiology of Disease. 43(1). 184–189. 40 indexed citations
7.
Baron, Frédéric, Chantal Lechanteur, Évelyne Willems, et al.. (2010). Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning. Biology of Blood and Marrow Transplantation. 16(6). 838–847. 160 indexed citations
8.
Castermans, Emilie, Jacques Dutrieux, Stéphanie Humblet‐Baron, et al.. (2010). Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age. Haematologica. 96(2). 298–306. 62 indexed citations
9.
Daly, Adrian, Anne Barlier, Marie‐Lise Jaffrain‐Rea, et al.. (2009). High Incidence of AIP mutations in sporadic pituitary adenomas in young patients with macroadenomas. Open Repository and Bibliography (University of Liège). 5 indexed citations
10.
Fajardo, Carmen, Adrian Daly, Jean-François Vanbellinghen, et al.. (2009). TSH-secreting pituitary adenoma in a male patient with a novel missense AIP mutation. 6 indexed citations
11.
Mutesa, Léon, Jean-François Vanbellinghen, Anne‐Cecile Hellin, et al.. (2009). Deletion of Xpter encompassing the SHOX gene and PAR1 region in familial patients with Leri-Weill Dyschondrosteosis syndrome.. PubMed. 20(1). 9–17. 3 indexed citations
12.
Yaneva, Maria, Adrian Daly, María A. Tichomirowa, et al.. (2008). Aryl Hydrocarbon Receptor interacting Protein Gene Mutations in Bulgarian FIPA and Young Sporadic Pituitary Adenoma Patients. Open Repository and Bibliography (University of Liège). 7 indexed citations
13.
Beckers, Albert, Jean-François Vanbellinghen, Sosipatros A. Boikos, et al.. (2008). Germline AIP, MEN1, PRKAR1A, CDKN1B (p27Kip1) and CDKN2C (p18INK4c) gene mutations in a large cohort of pediatric patients with pituitary adenomas occurring in isolation or with associated syndromic features. Open Repository and Bibliography (University of Liège). 10 indexed citations
14.
Mutesa, Léon, et al.. (2008). Spinocerebellar Ataxia Type 2 (SCA2): Clinical Features and Genetic Analysis. Journal of Tropical Pediatrics. 54(5). 350–352. 12 indexed citations
15.
Daly, Adrian, Jean-François Vanbellinghen, & Albert Beckers. (2007). Characteristics of familial isolated pituitary adenomas. Expert Review of Endocrinology & Metabolism. 2(6). 725–733.
16.
Naves, Luciana Ansaneli, Adrian Daly, Jean-François Vanbellinghen, et al.. (2007). Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene. European Journal of Endocrinology. 157(4). 383–391. 66 indexed citations
17.
Boemer, François, Jean-François Vanbellinghen, Vincent Bours, & Roland Schoos. (2006). Screening for sickle cell disease on dried blood: a new approach evaluated on 27,000 Belgian newborns. Journal of Medical Screening. 13(3). 132–136. 9 indexed citations
18.
Vanbellinghen, Jean-François, Albert Beckers, & Jacques Poncin. (1999). Preliminary characterization of the promoter and CIS-regulatory elements of the MEN1 gene. Open Repository and Bibliography (University of Liège). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ken Morii Breakdown of academic impact, for papers by Heather A. O’Leary Breakdown of academic impact, for papers by Robert Bayer Breakdown of academic impact, for papers by Balázs Csernus Breakdown of academic impact, for papers by Jeffrey S. Huo Breakdown of academic impact, for papers by Dag Josefsen Breakdown of academic impact, for papers by Maree V. Hammett Breakdown of academic impact, for papers by Marta Albajar Breakdown of academic impact, for papers by Francesca Crosti Breakdown of academic impact, for papers by Tomiaki Asai
Rankless by CCL
2026